Treatment of first-episode psychosis: efficacy and tolerability of a long-acting typical antipsychotic

被引：0
|
作者：
Chiliza, B. [1 ]
Schoeman, R. [1 ]
Emsley, R. [1 ]
Oosthuizen, P. [1 ]
Koen, L. [1 ]
Niehaus, D. [1 ]
Hawkridge, S. [1 ]
机构：
[1] Univ Stellenbosch, Cape Town, South Africa
来源：
EARLY INTERVENTION IN PSYCHIATRY | 2008年 / 2卷
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：A81 / A81
页数：1
相关论文
共 50 条
  • [31] Antipsychotic treatment resistance in first-episode psychosis: prevalence, subtypes and predictors
    Demjaha, A.
    Lappin, J. M.
    Stahl, D.
    Patel, M. X.
    MacCabe, J. H.
    Howes, O. D.
    Heslin, M.
    Reininghaus, U. A.
    Donoghue, K.
    Lomas, B.
    Charalambides, M.
    Onyejiaka, A.
    Fearon, P.
    Jones, P.
    Doody, G.
    Morgan, C.
    Dazzan, P.
    Murray, R. M.
    PSYCHOLOGICAL MEDICINE, 2017, 47 (11) : 1981 - 1989
  • [32] Long-acting injectable antipsychotic medication after a first episode of schizophrenia
    不详
    EARLY INTERVENTION IN PSYCHIATRY, 2012, 6 : 7 - 7
  • [33] Immunomodulatory effects of antipsychotic treatment on gene expression in first-episode psychosis
    Mantere, Outi
    Trontti, Kalevi
    Garcia-Gonzalez, Judit
    Balcells, Ingrid
    Saarnio, Suvi
    Mantyla, Teemu
    Lindgren, Maija
    Kieseppa, Tuula
    Raij, Tuukka
    Honkanen, Jarno K.
    Vaarala, Outi
    Hovatta, Iiris
    Suvisaari, Jaana
    JOURNAL OF PSYCHIATRIC RESEARCH, 2019, 109 : 18 - 26
  • [34] Profiling of lipidomics before and after antipsychotic treatment in first-episode psychosis
    Liisa Leppik
    Madis Parksepp
    Sven Janno
    Kati Koido
    Liina Haring
    Eero Vasar
    Mihkel Zilmer
    European Archives of Psychiatry and Clinical Neuroscience, 2020, 270 : 59 - 70
  • [35] Prevalence, Predictors, and Consequences of Long-Term Refusal of Antipsychotic Treatment in First-Episode Psychosis
    Lambert, Martin
    Conus, Philippe
    Cotton, Sue
    Robinson, Jo
    McGorry, Patrick D.
    Schimmelmann, Benno G.
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2010, 30 (05) : 565 - 572
  • [36] Profiling of lipidomics before and after antipsychotic treatment in first-episode psychosis
    Leppik, Liisa
    Parksepp, Madis
    Janno, Sven
    Koido, Kati
    Haring, Liina
    Vasar, Eero
    Zilmer, Mihkel
    EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2020, 270 (01) : 59 - 70
  • [37] White Matter Changes Associated with Antipsychotic Treatment in First-Episode Psychosis
    Philip R Szeszko
    Delbert G Robinson
    Toshikazu Ikuta
    Bart D Peters
    Juan A Gallego
    John Kane
    Anil K Malhotra
    Neuropsychopharmacology, 2014, 39 : 1324 - 1331
  • [38] Schizophrenia Polygenic Risk Score as a Predictor of Antipsychotic Efficacy in First-Episode Psychosis
    Zhang, Jian-Ping
    Robinson, Delbert
    Yu, Jin
    Gallego, Juan
    Fleischhacker, W. Wolfgang
    Kahn, Rene S.
    Crespo-Facorro, Benedicto
    Vazquez-Bourgon, Javier
    Kane, John M.
    Malhotra, Anil K.
    Lencz, Todd
    AMERICAN JOURNAL OF PSYCHIATRY, 2019, 176 (01): : 21 - 28
  • [39] Remission in patients with first-episode schizophrenia receiving assured antipsychotic medication: a study with risperidone long-acting injection
    Emsley, Robin
    Oosthuizen, Petrus
    Koen, Liezl
    Niehaus, Dana J. H.
    Medori, Rossella
    Rabinowitz, Jonathan
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2008, 23 (06) : 325 - 331
  • [40] Long-Acting Injectable Antipsychotics for First-Episode Schizophrenia: The Pros and Cons
    Kim, Borah
    Lee, Sang-Hyuk
    Yang, Yen Kuang
    Park, Jong-Il
    Chung, Young-Chul
    SCHIZOPHRENIA RESEARCH AND TREATMENT, 2012, 2012
12345